REMEGEN (09995) reported a net profit attributable to shareholders of RMB5.273 billion for the first three quarters.
REMEGEN (09995) announced that for the first three quarters of 2026, operating revenue was RMB6.764 billion, a year-on-year increase of 293.28%; net profit attributable to shareholders of the listed company was RMB5.273 billion, compared with a loss of RMB551 million in the same period last year; basic earnings per share were RMB9.41.
REMEGEN (09995) announced that for the first three quarters of 2026, operating revenue was RMB6.764 billion, up 293.28% year on year; net profit attributable to shareholders of the listed company was RMB5.273 billion, compared with a loss of RMB551 million in the same period last year; basic earnings per share were RMB9.41.
Related Articles
BEKE-W (02423) repurchased approximately 431,800 shares for approximately US$2.5 million on October 28.
SIRNAOMICS-B (02257) Grants Share Options and Restricted Share Units
Microsoft Corporation (MSFT.US) returns to the U.S. investment-grade bond market after 9 years, plans to raise $25 billion to ramp up AI investment.
BEKE-W (02423) repurchased approximately 431,800 shares for approximately US$2.5 million on October 28.
SIRNAOMICS-B (02257) Grants Share Options and Restricted Share Units
Microsoft Corporation (MSFT.US) returns to the U.S. investment-grade bond market after 9 years, plans to raise $25 billion to ramp up AI investment.
